These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 32852058)

  • 21. Ca
    Straus MR; Tang T; Lai AL; Flegel A; Bidon M; Freed JH; Daniel S; Whittaker GR
    J Virol; 2020 Jun; 94(13):. PubMed ID: 32295925
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Properties of Coronavirus and SARS-CoV-2.
    Malik YA
    Malays J Pathol; 2020 Apr; 42(1):3-11. PubMed ID: 32342926
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microneedle array delivered recombinant coronavirus vaccines: Immunogenicity and rapid translational development.
    Kim E; Erdos G; Huang S; Kenniston TW; Balmert SC; Carey CD; Raj VS; Epperly MW; Klimstra WB; Haagmans BL; Korkmaz E; Falo LD; Gambotto A
    EBioMedicine; 2020 May; 55():102743. PubMed ID: 32249203
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Photoactivable Natural Product with Broad Antiviral Activity against Enveloped Viruses, Including Highly Pathogenic Coronaviruses.
    Meunier T; Desmarets L; Bordage S; Bamba M; Hervouet K; Rouillé Y; François N; Decossas M; Sencio V; Trottein F; Tra Bi FH; Lambert O; Dubuisson J; Belouzard S; Sahpaz S; Séron K
    Antimicrob Agents Chemother; 2022 Feb; 66(2):e0158121. PubMed ID: 34807755
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A perspective on potential target proteins of COVID-19: Comparison with SARS-CoV for designing new small molecules.
    Kumar D; Chauhan G; Kalra S; Kumar B; Gill MS
    Bioorg Chem; 2020 Nov; 104():104326. PubMed ID: 33142431
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice.
    Sheahan TP; Sims AC; Zhou S; Graham RL; Pruijssers AJ; Agostini ML; Leist SR; Schäfer A; Dinnon KH; Stevens LJ; Chappell JD; Lu X; Hughes TM; George AS; Hill CS; Montgomery SA; Brown AJ; Bluemling GR; Natchus MG; Saindane M; Kolykhalov AA; Painter G; Harcourt J; Tamin A; Thornburg NJ; Swanstrom R; Denison MR; Baric RS
    Sci Transl Med; 2020 Apr; 12(541):. PubMed ID: 32253226
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug Discovery Strategies for SARS-CoV-2.
    Shyr ZA; Gorshkov K; Chen CZ; Zheng W
    J Pharmacol Exp Ther; 2020 Oct; 375(1):127-138. PubMed ID: 32723801
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A mouse model for Betacoronavirus subgroup 2c using a bat coronavirus strain HKU5 variant.
    Agnihothram S; Yount BL; Donaldson EF; Huynh J; Menachery VD; Gralinski LE; Graham RL; Becker MM; Tomar S; Scobey TD; Osswald HL; Whitmore A; Gopal R; Ghosh AK; Mesecar A; Zambon M; Heise M; Denison MR; Baric RS
    mBio; 2014 Mar; 5(2):e00047-14. PubMed ID: 24667706
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency.
    Gordon CJ; Tchesnokov EP; Woolner E; Perry JK; Feng JY; Porter DP; Götte M
    J Biol Chem; 2020 May; 295(20):6785-6797. PubMed ID: 32284326
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Coronaviruses lacking exoribonuclease activity are susceptible to lethal mutagenesis: evidence for proofreading and potential therapeutics.
    Smith EC; Blanc H; Surdel MC; Vignuzzi M; Denison MR
    PLoS Pathog; 2013 Aug; 9(8):e1003565. PubMed ID: 23966862
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Replication-transcription complex of coronaviruses: functions of individual viral non-structural subunits, properties and architecture of their complexes.
    Mishchenko EL; V A Ivanisenko VA
    Vavilovskii Zhurnal Genet Selektsii; 2022 Mar; 26(2):121-127. PubMed ID: 35434485
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting Crucial Host Factors of SARS-CoV-2.
    Tharappel AM; Samrat SK; Li Z; Li H
    ACS Infect Dis; 2020 Nov; 6(11):2844-2865. PubMed ID: 33112126
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structural-based virtual screening and in vitro assays for small molecules inhibiting the feline coronavirus 3CL protease as a surrogate platform for coronaviruses.
    Theerawatanasirikul S; Kuo CJ; Phecharat N; Chootip J; Lekcharoensuk C; Lekcharoensuk P
    Antiviral Res; 2020 Oct; 182():104927. PubMed ID: 32910955
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus.
    Gordon CJ; Tchesnokov EP; Feng JY; Porter DP; Götte M
    J Biol Chem; 2020 Apr; 295(15):4773-4779. PubMed ID: 32094225
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In-silico nucleotide and protein analyses of S-gene region in selected zoonotic coronaviruses reveal conserved domains and evolutionary emergence with trajectory course of viral entry from SARS-CoV-2 genomic data.
    Obajuluwa AO; Okiki PA; Obajuluwa TM; Afolabi OB
    Pan Afr Med J; 2020; 37():285. PubMed ID: 33654512
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MOV10 Helicase Interacts with Coronavirus Nucleocapsid Protein and Has Antiviral Activity.
    Wang L; Sola I; Enjuanes L; Zuñiga S
    mBio; 2021 Oct; 12(5):e0131621. PubMed ID: 34517762
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Review of Human Coronaviruses' Receptors: The Host-Cell Targets for the Crown Bearing Viruses.
    Nassar A; Ibrahim IM; Amin FG; Magdy M; Elgharib AM; Azzam EB; Nasser F; Yousry K; Shamkh IM; Mahdy SM; Elfiky AA
    Molecules; 2021 Oct; 26(21):. PubMed ID: 34770863
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiviral activity against Middle East Respiratory Syndrome coronavirus by Montelukast, an anti-asthma drug.
    Gan HJ; Harikishore A; Lee J; Jeon S; Rajan S; Chen MW; Neo JL; Kim S; Yoon HS
    Antiviral Res; 2021 Jan; 185():104996. PubMed ID: 33309540
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Middle East respiratory syndrome coronavirus (MERS-CoV) entry inhibitors targeting spike protein.
    Xia S; Liu Q; Wang Q; Sun Z; Su S; Du L; Ying T; Lu L; Jiang S
    Virus Res; 2014 Dec; 194():200-10. PubMed ID: 25451066
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Coronavirus Entry Inhibitors.
    Lan Q; Xia S; Lu L
    Adv Exp Med Biol; 2022; 1366():101-121. PubMed ID: 35412137
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.